Cargando…

MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value

BACKGROUND: The average five-year survival for non-small cell lung cancer (NSCLC) patients is approximately 15%. Emerging evidence indicates that microRNAs (miRNAs) constitute a new class of gene regulators in humans that may play an important role in tumorigenesis. Hence, there is growing interest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallach, Sandra, Jantus-Lewintre, Eloisa, Calabuig-Fariñas, Silvia, Montaner, David, Alonso, Sergio, Sirera, Rafael, Blasco, Ana, Usó, Marta, Guijarro, Ricardo, Martorell, Miguel, Camps, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593550/ https://www.ncbi.nlm.nih.gov/pubmed/28915579 http://dx.doi.org/10.18632/oncotarget.18603

Ejemplares similares

MicroRNAs: Promising New Antiangiogenic Targets in Cancer
por: Gallach, Sandra, et al.
Publicado: (2014)

Characterization of Circulating T Cell Receptor Repertoire Provides Information about Clinical Outcome after PD-1 Blockade in Advanced Non-Small Cell Lung Cancer Patients
por: Dong, Ning, et al.
Publicado: (2021)

Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers
por: Usó, Marta, et al.
Publicado: (2016)

Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer
por: Herreros-Pomares, Alejandro, et al.
Publicado: (2019)

CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer
por: Moreno-Manuel, Andrea, et al.
Publicado: (2020)

Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung Cancer
por: Duréndez-Sáez, Elena, et al.
Publicado: (2022)

Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
por: Zhang, Feiyu, et al.
Publicado: (2021)

Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer
por: Puchades-Carrasco, Leonor, et al.
Publicado: (2016)

Potential Non-Invasive Biomarkers for Early Diagnosis of Oral Squamous Cell Carcinoma
por: Dikova, Valentina, et al.
Publicado: (2021)

Exosomal microRNAs in non-small cell lung cancer
por: Duréndez-Sáez, Elena, et al.
Publicado: (2021)

Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies
por: Palanca-Ballester, Cora, et al.
Publicado: (2021)

NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment
por: Sánchez‐Herrero, Estela, et al.
Publicado: (2021)

Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas
por: Bernaldo de Quirós, Sandra, et al.
Publicado: (2013)

Biological insights in non-small cell lung cancer
por: Rosell, Rafael, et al.
Publicado: (2023)

On the Oral Microbiome of Oral Potentially Malignant and Malignant Disorders: Dysbiosis, Loss of Diversity, and Pathogens Enrichment
por: Herreros-Pomares, Alejandro, et al.
Publicado: (2023)

Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer
por: Molina-Pinelo, Sonia, et al.
Publicado: (2016)

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer
por: García-Foncillas, Jesús, et al.
Publicado: (2018)

Interplay Between MicroRNAs and Oxidative Stress in Ovarian Conditions with a Focus on Ovarian Cancer and Endometriosis
por: Marí-Alexandre, Josep, et al.
Publicado: (2019)

TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients
por: Villalba, Maria, et al.
Publicado: (2019)

Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1
por: Villalba, Maria, et al.
Publicado: (2019)

Comprehensive cross‐platform comparison of methods for non‐invasive EGFR mutation testing: results of the RING observational trial
por: Romero, Atocha, et al.
Publicado: (2020)

Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study
por: Jantus-Lewintre, Eloisa, et al.
Publicado: (2021)

Modulating microRNAs in cancer: next-generation therapies
por: Arghiani, Nahid, et al.
Publicado: (2022)

Integrated gene set analysis for microRNA studies
por: Garcia-Garcia, Francisco, et al.
Publicado: (2016)

Next-generation sequencing of the Chinese hamster ovary microRNA transcriptome: Identification, annotation and profiling of microRNAs as targets for cellular engineering()
por: Hackl, Matthias, et al.
Publicado: (2011)

Next-Generation Sequencing of MicroRNAs for Breast Cancer Detection
por: Wu, Qian, et al.
Publicado: (2011)

MicroRNAs -the Next Generation Therapeutic Targets in Human Diseases
por: Srinivasan, Sakthivel, et al.
Publicado: (2013)

microRNAs and next generation sequencing for the prognosis of the metastatic melanoma
por: Pinto, Rosamaria, et al.
Publicado: (2015)

Next-generation sequencing of microRNAs in primary human polarized macrophages
por: Cobos Jiménez, Viviana, et al.
Publicado: (2014)

Blocking of targeted microRNAs from next-generation sequencing libraries
por: Roberts, Brian S., et al.
Publicado: (2015)

Evaluation of methodologies for microRNA biomarker detection by next generation sequencing
por: Coenen-Stass, Anna M.L., et al.
Publicado: (2018)

MicroRNA Expression in Pseudoexfoliation Syndrome with the Use of Next-Generation Sequencing
por: Tomczyk-Socha, Martyna, et al.
Publicado: (2022)

Prognostic Values of microRNAs in Colorectal Cancer
por: Xi, Yaguang, et al.
Publicado: (2007)

The microRNAs: Small size, big value,…
por: Solaroglu, Ihsan, et al.
Publicado: (2010)

R-Score: A New Parameter to Assess the Quality of Variants’ Calls Assessed by NGS Using Liquid Biopsies
por: Serna-Blasco, Roberto, et al.
Publicado: (2021)

New methods for next generation sequencing based microRNA expression profiling
por: Buermans, Henk PJ, et al.
Publicado: (2010)

Circulating microRNAs: next-generation biomarkers for early lung cancer detection
por: Bianchi, F, et al.
Publicado: (2012)

Discovery and Validation of Barrett's Esophagus MicroRNA Transcriptome by Next Generation Sequencing
por: Bansal, Ajay, et al.
Publicado: (2013)

Identification and Characterization of MicroRNAs in Normal Equine Tissues by Next Generation Sequencing
por: Kim, Myung-Chul, et al.
Publicado: (2014)

Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy
por: Koperski, Łukasz, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lukp0iqm9m6r3ehqe1rd0b4o1r